Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


CerTest Biotec and medical technology company Becton, Dickinson and Company (BDX) today announced that VIASURE SARS-CoV-2 (N1 + N2) Real Time PCR Detection Kit for the BD MAX Molecular Diagnostic System can now be run on saliva specimens.


RTTNews | Apr 27, 2021 07:53AM EDT

07:53 Tuesday, April 27, 2021 (RTTNews.com) - CerTest Biotec and medical technology company Becton, Dickinson and Company (BDX) today announced that VIASURE SARS-CoV-2 (N1 + N2) Real Time PCR Detection Kit for the BD MAX Molecular Diagnostic System can now be run on saliva specimens.

BD MAX System users now have three alternatives for specimen collection including nasopharyngeal, oropharyngeal and saliva.

This CE marked kit detects all currently identified variants of SARS-CoV-2, the companies said.

"This new specimen type alternative for VIASURE SARS-CoV-2 (N1+N2) Real Time PCR Detection Kit for the BD MAX System is complementing our versatile respiratory menu and is one step further in our goal to reach more patients with the right test and at the right time," said Nikos Pavlidis, vice president of Molecular Diagnostics at BD.

Read the original article on RTTNews ( https://www.rttnews.com/3188471/bd-certest-biotec-say-their-real-time-pcr-detection-kit-can-now-run-on-saliva-specimens.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC